Your browser doesn't support javascript.
Corowa-kun: A messenger app chatbot delivers COVID-19 vaccine information, Japan 2021.
Kobayashi, Takaaki; Nishina, Yuka; Tomoi, Hana; Harada, Ko; Tanaka, Kyuto; Matsumoto, Eiyu; Horimukai, Kenta; Ishihara, Jun; Sasaki, Shugo; Inaba, Kanako; Seguchi, Kyosuke; Takahashi, Hiromizu; Salinas, Jorge L; Yamada, Yuji.
  • Kobayashi T; Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA, USA. Electronic address: Takaaki-kobayashi@uiowa.edu.
  • Nishina Y; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Tomoi H; Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, Keppel Street, London, UK.
  • Harada K; Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.
  • Tanaka K; Department of Respiratory Medicine, Nippon Koukan Hospital, Kawasaki, Kanagawa, Japan.
  • Matsumoto E; Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
  • Horimukai K; Department of Pediatrics, Jikei University Katsushika Medical Center, Tokyo, Japan.
  • Ishihara J; Department of Bioengineering, Imperial College London, London, United Kingdom.
  • Sasaki S; Department of General Internal Medicine, Saitama Medical University Hospital, Moroyama, Saitama, Japan.
  • Inaba K; Department of Obstetrics and Gynecology, Kanto Central Hospital, Tokyo, Japan.
  • Seguchi K; Department of Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan.
  • Takahashi H; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
  • Salinas JL; Division of Infectious Diseases, Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
  • Yamada Y; Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Vaccine ; 40(32): 4654-4662, 2022 07 30.
Article in English | MEDLINE | ID: covidwho-1882614
ABSTRACT

BACKGROUND:

There is a long history in Japan of public concerns about vaccine adverse events. Few studies have assessed how mobile messenger apps affect COVID-19 vaccine hesitancy.

METHODS:

Corowa-kun, a free chatbot, was created on February 6, 2021 in LINE, the most popular messenger app in Japan. Corowa-kun provides instant, automated answers to 70 frequently asked COVID-19 vaccine questions. A cross-sectional survey with 21 questions was performed within Corowa-kun during April 5-12, 2021.

RESULTS:

A total of 59,676 persons used Corowa-kun during February-April 2021. Of them, 10,192 users (17%) participated in the survey. Median age was 55 years (range 16-97), and most were female (74%). COVID-19 vaccine hesitancy reported by survey respondents decreased from 41% to 20% after using Corowa-kun. Of the 20% who remained hesitant, 16% (1,675) were unsure, and 4% (364) did not intend to be vaccinated. Factors associated with vaccine hesitancy were age 16-34 (odds ratio [OR] = 3.7; 95% confidential interval [CI] 3.0-4.6, compared to age ≥ 65), female sex (OR = 2.4; Cl 2.1-2.8), and history of a previous vaccine side-effect (OR = 2.5; Cl 2.2-2.9). Being a physician (OR = 0.2; Cl 0.1-0.4) and having received a flu vaccine the prior season (OR = 0.4; Cl 0.3-0.4) were protective.

CONCLUSIONS:

A substantial number of people used the chabot in a short period. Mobile messenger apps could be leveraged to provide accurate vaccine information and to investigate vaccine intention and risk factors for vaccine hesitancy.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mobile Applications / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Vaccine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Mobile Applications / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Vaccine Year: 2022 Document Type: Article